Melanoma, Malignant Terminated Phase 1 / 2 Trials for AN-9 (DB05103)

Also known as: Malignant Melanoma / [M]Malignant melanoma NOS / Melanoma / Melanoma malignant

IndicationStatusPhase
DBCOND0107071 (Melanoma, Malignant)Terminated1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00087477A Pilot Study of Pivanex in Patients With Malignant MelanomaTreatment